Breaking News Instant updates and real-time market news.

CRME

Cardiome

$3.81

0.06 (1.60%)

07:34
06/12/17
06/12
07:34
06/12/17
07:34

Cardiome announces commercial launch of BRINAVESS in Canada

Cardiome Pharma announced that it received authorization from Health Canada to begin selling BRINAVESS and has subsequently launched BRINAVESS in Canada. BRINAVESS is indicated for the rapid conversion of recent onset atrial fibrillation to sinus rhythm for: non-surgery patients with AF less than 7 days; and post-cardiac surgery patients with duration of AF less than 3 days. BRINAVESS is not recommended for conversion of atrial flutter to sinus rhythm. The product is currently available on the Ontario formulary, with a broader launch anticipated in the third quarter of this year as more provinces are expected to include BRINAVESS in the provincial formularies.

CRME Cardiome
$3.81

0.06 (1.60%)

12/22/16
LEER
12/22/16
INITIATION
Target $4.75
LEER
Outperform
Cardiome initiated with an Outperform at Leerink
Leerink analyst Jason Gerberry started Cardiome with an Outperform rating and $4.75 price target based on the company's ability to drive "meaningful operating and financial leverage" through the launch of several new products.
08/02/16
ADAM
08/02/16
NO CHANGE
Target $9
ADAM
Speculative Buy
Cardiome price target lowered to $9 from $13.75 at Canaccord
Canaccord lowered its price target on Cardiome to $9 from $13.75 following its secondary offering of shares at a "big discount" to the previous closing of the stock. The firm believes the discount has presented a buying opportunity, as the recent licensing deal for Xydalba accelerates the company's transformation into a European hospital-focused specialty pharmaceuticals company. Canaccord reiterated its Speculative Buy rating on Cardiome shares.

TODAY'S FREE FLY STORIES

ADP

ADP

$111.10

-0.48 (-0.43%)

13:21
08/17/17
08/17
13:21
08/17/17
13:21
Recommendations
ADP analyst commentary  »

ADP will have difficulty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

  • 11

    Sep

NAK

Northern Dynasty

$1.56

0.065 (4.36%)

13:20
08/17/17
08/17
13:20
08/17/17
13:20
Options
Call buyers back in Northern Dynasty Minerals »

Call buyers back in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLS

Celestica

$11.55

-0.035 (-0.30%)

13:17
08/17/17
08/17
13:17
08/17/17
13:17
Upgrade
Celestica rating change  »

Follow-up: Celestica…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSRO

Tesaro

$112.99

-1.01 (-0.89%)

, AZN

AstraZeneca

$29.12

-0.0637 (-0.22%)

13:17
08/17/17
08/17
13:17
08/17/17
13:17
Hot Stocks
Breaking Hot Stocks news story on Tesaro, AstraZeneca »

Tesaro drops 2% after FDA…

TSRO

Tesaro

$112.99

-1.01 (-0.89%)

AZN

AstraZeneca

$29.12

-0.0637 (-0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 08

    Sep

  • 08

    Sep

$NSD

NASDAQ Market Internals

13:17
08/17/17
08/17
13:17
08/17/17
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZN

AstraZeneca

$29.11

-0.07 (-0.24%)

13:16
08/17/17
08/17
13:16
08/17/17
13:16
Hot Stocks
FDA posts approval of new dosage form for AstraZeneca's Lynparza 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Sep

  • 08

    Sep

$NYE

NYSE Market Internals

13:16
08/17/17
08/17
13:16
08/17/17
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTL

CenturyLink

$19.72

-1.17 (-5.60%)

, LVLT

Level 3

$53.45

-1.73 (-3.14%)

13:13
08/17/17
08/17
13:13
08/17/17
13:13
Hot Stocks
CenturyLink says working to finalize Level 3 deal by end of Q3 »

CenturyLink (CTL) said in…

CTL

CenturyLink

$19.72

-1.17 (-5.60%)

LVLT

Level 3

$53.45

-1.73 (-3.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTL

CenturyLink

$19.73

-1.16 (-5.55%)

, LVLT

Level 3

$53.45

-1.73 (-3.14%)

13:12
08/17/17
08/17
13:12
08/17/17
13:12
Hot Stocks
Breaking Hot Stocks news story on CenturyLink, Level 3 »

CenturyLink says working…

CTL

CenturyLink

$19.73

-1.16 (-5.55%)

LVLT

Level 3

$53.45

-1.73 (-3.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADP

ADP

$111.10

-0.48 (-0.43%)

13:10
08/17/17
08/17
13:10
08/17/17
13:10
Options
ADP attracts put buyers as shares come under fire »

ADP attracts put buyers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

  • 11

    Sep

ADOM

Adomani

$12.86

0.86 (7.17%)

, VLKAY

Volkswagen

$31.10

0.19 (0.61%)

13:06
08/17/17
08/17
13:06
08/17/17
13:06
Hot Stocks
Adomani sees $2.9B in settlement funds from Volkswagen »

Adomani (ADOM) announced…

ADOM

Adomani

$12.86

0.86 (7.17%)

VLKAY

Volkswagen

$31.10

0.19 (0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HZNP

Horizon Pharma

$11.89

-0.05 (-0.42%)

13:05
08/17/17
08/17
13:05
08/17/17
13:05
Options
Horizon Pharma call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLS

Celestica

$11.50

-0.08 (-0.69%)

13:04
08/17/17
08/17
13:04
08/17/17
13:04
Upgrade
Celestica rating change  »

Celestica upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDVX

Medovex

$0.95

0.05 (5.56%)

12:55
08/17/17
08/17
12:55
08/17/17
12:55
Hot Stocks
Medovex names Charlie Farrahar as CFO »

Medovex reported it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFE

Pfizer

$33.20

-0.16 (-0.48%)

12:53
08/17/17
08/17
12:53
08/17/17
12:53
Hot Stocks
FDA posts approval of Pfizer's biologic license qpplication for Besponsa 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 28

    Aug

  • 08

    Sep

  • 08

    Sep

  • 13

    Sep

NADL

North Atlantic Drilling

$1.44

-0.075 (-4.97%)

12:50
08/17/17
08/17
12:50
08/17/17
12:50
Options
Notable put spread in North Atlantic Drilling »

Notable put spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

12:45
08/17/17
08/17
12:45
08/17/17
12:45
General news
Breaking General news story  »

Dallas Federal Reserve…

HRB

H&R Block

$30.21

-0.53 (-1.72%)

12:40
08/17/17
08/17
12:40
08/17/17
12:40
Options
Higher option volume in H&R Block driven by call buying »

Higher option volume in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

  • 14

    Sep

EXPE

Expedia

$148.78

1.72 (1.17%)

12:35
08/17/17
08/17
12:35
08/17/17
12:35
Options
Expedia put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:35
08/17/17
08/17
12:35
08/17/17
12:35
General news
Treasury Option Action: call buying at the long-end »

Treasury Option Action:…

ADP

ADP

$111.10

-0.48 (-0.43%)

12:32
08/17/17
08/17
12:32
08/17/17
12:32
Hot Stocks
Chapman says making dollar going against Ackman feels as good as $10 »

Robert Chapman of Chapman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

  • 11

    Sep

ADP

ADP

$111.10

-0.48 (-0.43%)

12:31
08/17/17
08/17
12:31
08/17/17
12:31
Hot Stocks
Breaking Hot Stocks news story on ADP »

Pershing Square's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

  • 11

    Sep

ADP

ADP

$111.10

-0.48 (-0.43%)

12:28
08/17/17
08/17
12:28
08/17/17
12:28
Hot Stocks
Breaking Hot Stocks news story on ADP »

Robert Chapman discusses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

  • 11

    Sep

SPY

SPDR S&P 500 ETF Trust

$245.04

-1.9 (-0.77%)

, SPX

S&P 500

12:28
08/17/17
08/17
12:28
08/17/17
12:28
Technical Analysis
Technical View: S&P 500 hits lows of the day at midsession »

The S&P 500 (SPX) was…

SPY

SPDR S&P 500 ETF Trust

$245.04

-1.9 (-0.77%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Wal-Mart

$79.14

-1.84 (-2.27%)

, BABA

Alibaba

$166.91

7.4092 (4.65%)

12:25
08/17/17
08/17
12:25
08/17/17
12:25
General news
On The Fly: Top stock stories at midday »

Stocks opened in negative…

WMT

Wal-Mart

$79.14

-1.84 (-2.27%)

BABA

Alibaba

$166.91

7.4092 (4.65%)

AMZN

Amazon.com

$978.18

-4.56 (-0.46%)

AABA

Altaba

$60.65

0.66 (1.10%)

LB

L Brands

$35.15

-3.805 (-9.77%)

NTAP

NetApp

$42.41

0.44 (1.05%)

CSCO

Cisco

$32.34

0.25 (0.78%)

CTL

CenturyLink

$19.83

-1.06 (-5.07%)

LVLT

Level 3

$53.60

-1.58 (-2.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

  • 17

    Aug

  • 17

    Aug

  • 18

    Aug

  • 23

    Aug

  • 24

    Aug

  • 06

    Sep

  • 06

    Sep

  • 14

    Sep

  • 16

    Nov

  • 20

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.